Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - CASH FROM OPERATIONS
Cash from Operations MBRX - Moleculin Biotech, Inc.
-24.1 M
LAST VALUE
-12.77%
2 YEAR CAGR
-14.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR